- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 31, 2025 | 73.9M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 76M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 75.5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 74.5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 73.7M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $80M |
| Capex | Q3 2025 · Sep 30, 2024 | $69M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $125M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $264M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $2.79B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $2.86B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $80M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $81M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $412M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $419M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $395M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $330M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $219M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $1.78B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.72B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $5.32B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $5.31B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.82B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.75B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $5.65B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $5.54B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.34 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.05 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.28 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.53 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.35 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.08 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.29 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.54 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $143M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $381M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $127M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $391M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $18M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $52M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $15M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $43M |
| Net Income | Q3 2025 · Sep 30, 2025 | $26M |
| Net Income | Q3 2025 · Sep 30, 2025 | $79M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $21M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $39M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $110M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $322M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $114M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $288M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.12B |
| Revenue | Q3 2025 · Sep 30, 2025 | $3.2B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $1.07B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $3.2B |